ACTRN12621000684820尚未招募1 期
The effect of Sodium-Glucose Co-Transporter 2 inhibition prior to cardiac surgery on intraoperative electrophysiologic parameters and post-operative atrial fibrillation: a pilot randomised controlled trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Participants undergoing planned elective cardiac surgery (> 1 month prior to surgical date at time of enrolment)
排除标准
- •Patients who are unable or unwilling to provide consent.
- •Patients who do not have access to a smartphone.
- •Patients who do not consent to study coordinator discussing their involvement with their GP.
- •Contraindications to SGLT2 commencement; patients already taking SGLT2 inhibitors, history of impaired kidney function (eGFR <45mL/min/1.73m2), Child –Pugh C cirrhosis, pregnancy, breastfeeding, symptomatic hypotension/ systolic blood pressure <100mmHg, type 1 diabetes mellitus, or previous SGLT2 intolerance or allergy, in line with current published contraindications to therapy.
研究者
相似试验
尚未招募
Unknown
The effects Of sodium-glucose coTransporter 2 inhibiTOR on fastIng Hepatic Insulin Clearance in type 2 diabetesJPRN-jRCT1061230070Okura Tsuyoshi20
尚未招募
1 期
Sodium-glucose co-transporter 2 inhibition prior to atrial fibrillation ablation: A pilot randomised controlled trialCardiovascular - Other cardiovascular diseasesAtrial fibrillationACTRN12621000685819Flinders University60
已完成
4 期
Effect of SGLT2 inhibitors on heart function in type 2 diabetic patients in south IndiaCTRI/2020/02/023195izams Institute of Medical Sciences
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
已完成
不适用
Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018367Ise Red Cross Hospital Department of Metabolic Diseases30